Dow Up 1.79% Nasdaq Up 2.03%

Argos Therapeutics, Inc. (ARGS)

-NasdaqGM
9.20 Up 0.31(3.49%) 2:14PM EDT - Nasdaq Real Time Price
Prev Close:8.89
Open:9.16
Bid:9.16 x 200
Ask:9.25 x 500
1y Target Est:17.50
Beta:N/A
Next Earnings Date:13-Nov-14ARGS Earnings announcement
Day's Range:8.82 - 9.20
52wk Range:5.61 - 13.74
Volume:28,694
Avg Vol (3m):50,902
Market Cap:180.83M
P/E (ttm):N/A
EPS (ttm):-6.08
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARGS

Comparison

Symbol% ChgMkt Cap
ARGSUp 3.49%180.83M
ONXX 0.00%N/A
PFEUp 1.80%182.68B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):58.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.56
Quarterly EPS Est (Sep-14) :-0.55
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Argos Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of personalized immunotherapies for the treatment of cancer and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback